CureVac N.V. Files October 2025 6-K Report
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | Oct 27, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
Related Tickers: CVAC
TL;DR
CureVac (CVAC) filed its monthly 6-K report on 10/27/2025.
AI Summary
CureVac N.V. filed a Form 6-K on October 27, 2025, for the month of October 2025. The report is filed under the Securities Exchange Act of 1934. CureVac N.V. is a foreign private issuer incorporated in Germany, with its principal executive office located in Tübingen.
Why It Matters
This filing provides routine updates for CureVac N.V. as a foreign private issuer, informing investors about their ongoing compliance and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- 001-39446 (company) — SEC File Number
- Tübingen, Germany (company) — Principal Executive Office Location
- 20251027 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was this specific Form 6-K filed?
This Form 6-K was filed on October 27, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
Is CureVac N.V. required to file annual reports under Form 20-F or Form 40-F?
CureVac N.V. indicates it files annual reports under Form 20-F.
What is the SEC File Number for CureVac N.V.?
The SEC File Number for CureVac N.V. is 001-39446.
Filing Stats: 319 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-10-27 06:01:26
Filing Documents
- tm2529451d1_6k.htm (6-K) — 13KB
- tm2529451d1_ex99-1.htm (EX-99.1) — 60KB
- tm2529451d1_ex99-2.htm (EX-99.2) — 7KB
- tm2529451d1_ex99-3.htm (EX-99.3) — 49KB
- tm2529451d1_ex99-4.htm (EX-99.4) — 39KB
- tm2529451d1_ex99-2img001.jpg (GRAPHIC) — 113KB
- tm2529451d1_ex99-2img002.jpg (GRAPHIC) — 112KB
- 0001104659-25-102252.txt ( ) — 473KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CureVac N.V. (Registrant) Date: October 24, 2025 By: /s/ Alexander Zehnder Chief Executive Officer EXHIBIT INDEX EXHIBIT NO. DESCRIPTION 99.1 Convening notice to the extraordinary general meeting of shareholders including agenda and explanatory notes. 99.2 Voting proxy. 99.3 Merger proposal 99.4 Explanatory notes to the merger proposal